Accessibility Menu
Akanda logo

Akanda(NASDAQ) AKAN

Current Price$11.98
Market Cap$6.34MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2022)-100%
5 YearN/A
1 Year-91%
1 Month-50%
Akanda last closing stock price
MetricPriceDate
Last closeUSD 8.072026-07-23
Akanda stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-15.67%USD 9.572026-07-16
1 month-50.12%USD 16.182026-06-23
3 month-34.01%USD 12.232026-04-24
Year to date-21.57%USD 10.292025-12-31
1 year-91.1%USD 90.702025-07-23
3 year-99.78%USD 3,661.882023-07-24
Since inception-100%USD 590,624.262022-03-15

Akanda Financials at a Glance

Market Cap

$6.34MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.09M

Net Income (TTM)

-$49.67M

EPS (TTM)

-$145.41

P/E Ratio

-0.06

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$11.98

Volume

58,103

Open

$9.79

Previous Close

$8.07

Daily Range

$8.72 - $13.87

52-Week Range

$2.30 - $209.03

Estimated Earnings Date

Apr 29, 2026

AKAN News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Akanda

Akanda Corp. is a healthcare company focused on the cultivation, production, and distribution of cannabis products for medical and wellness purposes. Operating through various subsidiaries, the company has a presence in the United Kingdom, Lesotho, and other global regions. Established in 2021, Akanda Corp. aims to meet the growing demand for cannabis-derived items.

Products and Services
  • Cultivation of cannabis plants for medical use
  • Production of cannabis-derived wellness products
  • Distribution of products across multiple global markets
Growth Outlook
  • Expansion into new markets is anticipated to drive revenue growth
  • Increased consumer demand for medical cannabis products is expected
  • Strategic partnerships may enhance distribution capabilities
Financial Highlights
  • Recent quarterly revenue of $258,075 shows potential for growth
  • Trailing twelve months (TTM) revenue of $1,000,000 indicates market interest
  • Cash and cash equivalents of $503,562 provide liquidity for operations
Akanda Corp. operates in the rapidly evolving cannabis industry, which is experiencing significant growth due to increasing acceptance and demand for medical cannabis. The company's focus on cultivating and distributing cannabis products positions it well to capitalize on this trend. Recent financial data indicates a revenue of $258,075 for the latest quarter, reflecting the company's ability to generate income despite challenges. The TTM revenue of $1,000,000 further underscores the potential for future growth as the market expands. With a cash position of $503,562, Akanda Corp. maintains liquidity to support ongoing operations and strategic initiatives. Overall, the company's commitment to providing high-quality cannabis products aligns with the growing consumer demand in the healthcare sector.
AI Generated • Jul 21, 2026

Industry

Pharmaceuticals

Employees

8

CEO

Katharyn M. Field, MBA

Headquarters

New Romney, KE TN28 8XU, GB

AKAN Financials

Key Financial Metrics (TTM)

Gross Margin

-382.68%

Operating Margin

-2022.68%

Net Income Margin

-17658.53%

Return on Equity

1217.88%

Return on Capital

-144.39%

Return on Assets

-735.56%

Earnings Yield

-16.67%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$6.34MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

785.70K

Volume

58.10K

Avg. Volume

1.24M

Financials (TTM)

Gross Profit

-$779.22K

Operating Income

-$9.60M

EBITDA

-$7.88M

Operating Cash Flow

-$10.71M

Capital Expenditure

-$3.33M

Free Cash Flow

-$14.04M

Cash & ST Invst.

$503.56K

Total Debt

$14.24M

Akanda Performance Analysis

Akanda annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 2,619,6826223.0%
20232023-12-31USD 423,683-83.8%
20242024-12-31USD 0N/A
20252025-12-31USD 258,075N/A
Akanda sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-30-37.5%
Q42024-12-31-24.6%
Q22025-06-30-100.0%
Q42025-12-31N/A
Akanda annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -21,909.3838.4%
20232023-12-31USD -40,296.5483.9%
20242024-12-31USD -276.40-99.3%
20252025-12-31USD -669.96142.4%
Akanda sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-30100.0%
Q42024-12-3186.1%
Q22025-06-3016.2%
Q42025-12-31-1488.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$258.08K

-66.2%

Gross Profit

-$903.74K

-9.7%

Gross Margin

-3.50%

N/A

Market Cap

$6.34MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$792.53K

N/A

Employees

8

N/A

Net Income

-$44.76M

-69.6%

EBITDA

-$3.38M

-73.1%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

$503.56K

+436.4%

Total Debt

$14.24M

+256.0%

Accounts Receivable

$1.40M

+392.1%

Inventory

$0.00

-100.0%

Long Term Debt

$11.99M

+380.0%

Short Term Debt

$2.25M

+49.8%

Return on Assets

-7.36%

N/A

Return on Invested Capital

1370.08%

N/A

Free Cash Flow

-$7.59M

-1189.0%

Operating Cash Flow

-$6.35M

-978.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HSCSHeartSciences Inc.
$2.46+0.82%
GNPXGenprex, Inc.
$7.52+0.40%
UPCUniverse Pharmaceuticals Inc.
$3.51-7.39%
BBLGBone Biologics Corporation
$1.11+2.77%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.41-0.05%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$44.32+0.02%
MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares
$32.26-0.12%
TAT&T
$23.63+0.03%

Questions About AKAN

What is the current price of Akanda?

Akanda is trading at $11.98 per share.

What is the 52-week range for Akanda?

Over the past 52 weeks, Akanda has traded between $2.30 and $209.03.

How much debt does Akanda have?

As of the most recent reporting period, Akanda reported total debt of $14.24M.

How much cash does Akanda have on hand?

Akanda reported $504.14K in cash and cash equivalents in its most recent financial results.

What is Akanda’s dividend yield?

Akanda does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.